title: Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung.
authors.forename: R
authors.initials: R
authors.lastname: Carruthers
authors.forename: N
authors.initials: N
authors.lastname: O'Rourke
authors.forename: N
authors.initials: N
authors.lastname: Mohammed
authors.forename: J
authors.initials: J
authors.lastname: Hicks
authors.forename: I
authors.initials: I
authors.lastname: Brisbane
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000150:complications / Q000628:therapy*; D059248:Chemoradiotherapy; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D019583:Dose Fractionation, Radiation; D004417:Dyspnea / Q000139:chemically induced; D004941:Esophagitis / Q000139:chemically induced; D005500:Follow-Up Studies; D006801:Humans; D053609:Lethargy / Q000139:chemically induced; D008175:Lung Neoplasms / Q000150:complications / Q000628:therapy*; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine